11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Engineering materials for pyroptosis induction in cancer treatment

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancer remains a significant global health concern, necessitating the development of innovative therapeutic strategies. This research paper aims to investigate the role of pyroptosis induction in cancer treatment. Pyroptosis, a form of programmed cell death characterized by the release of pro-inflammatory cytokines and the formation of plasma membrane pores, has gained significant attention as a potential target for cancer therapy. The objective of this study is to provide a comprehensive overview of the current understanding of pyroptosis and its role in cancer treatment. The paper discusses the concept of pyroptosis and its relationship with other forms of cell death, such as apoptosis and necroptosis. It explores the role of pyroptosis in immune activation and its potential for combination therapy. The study also reviews the use of natural, biological, chemical, and multifunctional composite materials for pyroptosis induction in cancer cells. The molecular mechanisms underlying pyroptosis induction by these materials are discussed, along with their advantages and challenges in cancer treatment. The findings of this study highlight the potential of pyroptosis induction as a novel therapeutic strategy in cancer treatment and provide insights into the different materials and mechanisms involved in pyroptosis induction.

          Graphical abstract

          Highlights

          • Pyroptosis induction via engineering materials often sparks immune responses.

          • GSDM and caspases play key roles in pyroptosis molecular mechanisms.

          • Natural materials in pyroptosis reveal dual facets in cancer therapy.

          • Viruses and bacteria hold potential for inducing pyroptosis as biological agents.

          • Advantages and challenges in applying engineering materials in cancer therapy.

          Related collections

          Most cited references178

          • Record: found
          • Abstract: not found
          • Article: not found

          Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a Gasdermin

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cell death: a review of the major forms of apoptosis, necrosis and autophagy

            Cell death was once believed to be the result of one of two distinct processes, apoptosis (also known as programmed cell death) or necrosis (uncontrolled cell death); in recent years, however, several other forms of cell death have been discovered highlighting that a cell can die via a number of differing pathways. Apoptosis is characterised by a number of characteristic morphological changes in the structure of the cell, together with a number of enzyme-dependent biochemical processes. The result being the clearance of cells from the body, with minimal damage to surrounding tissues. Necrosis, however, is generally characterised to be the uncontrolled death of the cell, usually following a severe insult, resulting in spillage of the contents of the cell into surrounding tissues and subsequent damage thereof. Failure of apoptosis and the resultant accumulation of damaged cells in the body can result in various forms of cancer. An understanding of the pathways is therefore important in developing efficient chemotherapeutics. It has recently become clear that there exists a number of subtypes of apoptosis and that there is an overlap between apoptosis, necrosis and autophagy. The goal of this review is to provide a general overview of the current knowledge relating to the various forms of cell death, including apoptosis, necrosis, oncosis, pyroptosis and autophagy. This will provide researchers with a summary of the major forms of cell death and allow them to compare and contrast between them.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gasdermin E suppresses tumor growth by activating anti-tumor immunity

              Cleavage of the gasdermins to produce a pore-forming N-terminal fragment causes inflammatory death (pyroptosis) 1 . Caspase-3 cleaves gasdermin E (GSDME, also known as DFNA5), mutated in familial aging-related hearing loss 2 , which converts noninflammatory apoptosis to pyroptosis in GSDME-expressing cells 3–5 . GSDME expression is suppressed in many cancers and reduced GSDME is associated with decreased breast cancer survival 2,6 , suggesting GSDME might be a tumor suppressor. Here we show reduced GSDME function of 20 of 22 tested cancer-associated mutations. Gsdme knockout in GSDME-expressing tumors enhances, while ectopic expression in Gsdme-repressed tumors inhibits, tumor growth. Tumor suppression is mediated by cytotoxic lymphocyte killing since it is abrogated in perforin-deficient or killer lymphocyte-depleted mice. GSDME expression enhances tumor-associated macrophage phagocytosis and the number and functions of tumor-infiltrating NK and CD8+ T lymphocytes. Killer cell granzyme B also activates caspase-independent pyroptosis in target cells by directly cleaving GSDME at the same site as caspase-3. Non-cleavable or pore-defective GSDME are not tumor suppressive. Thus, tumor GSDME is a tumor suppressor by activating pyroptosis, which enhances anti-tumor immunity.
                Bookmark

                Author and article information

                Contributors
                Journal
                Bioact Mater
                Bioact Mater
                Bioactive Materials
                KeAi Publishing
                2452-199X
                07 November 2023
                March 2024
                07 November 2023
                : 33
                : 30-45
                Affiliations
                [a ]Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China
                [b ]Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China
                [c ]Department of Oncology, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, China
                [d ]Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
                [e ]Department of Biomedical Engineering, The City University of Hong Kong, Hong Kong Special Administrative Region of China
                Author notes
                []Corresponding author. Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China. liuxianling@ 123456csu.edu.cn
                [∗∗ ]Corresponding author. lizhihong@ 123456csu.edu.cn
                [∗∗∗ ]Corresponding author. yozhang@ 123456cityu.edu.hk
                Article
                S2452-199X(23)00342-0
                10.1016/j.bioactmat.2023.10.027
                10654002
                27ec7a0d-8699-4648-ad8e-0f2fd6b6eff3
                © 2023 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 3 September 2023
                : 24 October 2023
                : 26 October 2023
                Categories
                Review Article

                pyroptosis,engineering materials,cancer,treatment
                pyroptosis, engineering materials, cancer, treatment

                Comments

                Comment on this article